New Ventures Funds Rebrands as Scientia Ventures
New Ventures Funds has launched a new corporate brand identity and changed its name to Scientia Ventures. The new website for the firm can be found at: www.scientiavc.com. This reflects the broadening of the firm's strategic direction since launching its 3rd fund in 2017 to reflect its focus on transformational
PR Newswire · 10/02 11:00
Intra-Cellular Therapies Announces the Appointment of Dr. Suresh Durgam as Chief Medical Officer
NEW YORK, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced the promotion of Dr. Suresh Durgam to the position of Chief
GlobeNewswire · 10/01 21:30
Intra-Cellular Therapies: Navigating Choppy CNS Treatment Waters With Aplomb
Intra-Cellular won approval for Schizophrenia treatment Caplyta in Dec 2019 after a protracted review by the FDA. The marketing push began in Q1 but has been disrupted by COVID-19.The company looks set to follow up with a bipolar I and II approval based on positive data from 2 out of 3 phase 3 trials.These are huge markets and blockbuster sales may not be out of the question.With its science validated, Intra-Cellular also has a promising pipeline in development.There is a case to argue that the company is under-hyped and its shares could be worth as much as $60 based on DCF analysis. It would make an attractive acquisition target, in my view.
Seekingalpha · 09/30 22:36
PLM, REAL, SPI and BEAM among after-hours movers
Gainers: [[RLGT]] +11.3%. [[PLM]] +10.1%. [[DPW]] +6.7%. [[AFMD]] +6.6%. [[REAL]] +6.4%.Losers: [[AMBO]] -16.6%. [[SPI]] -6.8%. [[BEAM]] -5.5%. [[JAMF]] -4.5%. [[ITCI]] -4.3%.
Seekingalpha · 09/28 21:46
Insider Weekends: Tamara Gustavson Puts $8 Million Into Public Storage
Insider buying increased significantly last week.Notable Insider Buys: Public Storage, IGM Biosciences, Inc., Cassava Sciences, Inc., Intra-Cellular Therapies, Inc., Nikola Corporation.Notable Insider Sells: Scientific Games Corporation, Guardant Health, Inc., Antero Midstream Corporation, The Boston Beer Company, Inc., Zscaler, Inc.
Seekingalpha · 09/21 11:12
Intra-Cellular Therapies (ITCI) Investor Presentation - Slideshow
The following slide deck was published by Intra-Cellular Therapies, Inc. in conjunction with this event.
Seekingalpha · 09/17 23:20
Intra-Cellular Therapies to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman
GlobeNewswire · 09/15 12:00
Intra-Cellular Therapies to Present at the Cantor Virtual Global Healthcare Conference
NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman
GlobeNewswire · 09/14 13:00
What Kind Of Investors Own Most Of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)?
A look at the shareholders of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) can tell us which group is most powerful...
Simply Wall St. · 09/11 13:42
ITCI, AMRS among premarket losers
Evofem Biosciences (EVFM) -14%.Amyris (AMRS) -11% after Lavvan files $881M lawsuit.Muscle Maker (GRIL) -11%.Brigham Minerals (MNRL) -10% after pricing secondary offering.Satsuma Pharmaceuticals (STSA) -7% on yesterday's news of late-stage STS101 study and analysts downgrade.Spero Therapeutics (SPRO) -8% after pricing equity
Seekingalpha · 09/11 12:21
Stick With the Intra-Cellular Rally for Another 25% Upside, Says Analyst
TipRanks · 09/10 17:38
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Sarepta Flags Potential Delay In Gene Therapy Trial
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9)
Benzinga · 09/10 11:20
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company, today announced that it has commenced an underwritten public offering of $350 million of shares of its common stock. In connection with the offering, Intra-Cellular Therapies intends
GlobeNewswire · 09/09 21:01
Intra-Cellular commences $350M equity offering
Intra-Cellular Therapies (ITCI) launches a $350M public offering of common stock. Price, volume and terms have yet to be announced.Shares down 3% after hours.
Seekingalpha · 09/09 20:11
Mid-Afternoon Market Update: Nasdaq Surges 300 Points; Slack Shares Plunge
Toward the end of trading Wednesday, the Dow traded up 2.32% to 28140.09 while the NASDAQ rose 2.87% to 11,159.42. The S&P also rose, gaining 2.44% to 3,413.24.
Benzinga · 09/09 18:30
Positive Test Results For Bipolar Treatment Sends Intra-Cellular Stock Soaring
Investor's Business Daily · 09/09 17:19
Mid-Day Market Update: Dow Jumps Over 500 Points; Trillium Therapeutics Shares Spike Higher
Midway through trading Wednesday, the Dow traded up 1.90% to 28,024.77 while the NASDAQ rose 2.69% to 11,139.51. The S&P also rose, gaining 2.18% to 3,404.35.
Benzinga · 09/09 16:04
Intra-Cellular Therapies, Trillium Therapeutics leads gainers, Co-Diagnostics, Applied Genetic Technologies among losers
Gainers: Intra-Cellular Therapies (ITCI) +65%, Trillium Therapeutics (TRIL) +36%, Amryt Pharma (AMYT) +25%, BeyondSpring (BYSI) +18%, XTL Biopharmaceuticals (XTLB) +17%.Losers: Co-Diagnostics (CODX) -17%, Applied Genetic Technologies (AGTC) -16%, SCWorx (WORX) -10%, Innate Pharma (IPHA) -7%, PolarityTE (PTE) -5%.
Seekingalpha · 09/09 15:07
Mid-Morning Market Update: Markets Open Higher; AstraZeneca Halts Coronavirus Vaccine Study
Following the market opening Wednesday, the Dow traded up 1.65% to 27955.71 while the NASDAQ rose 1.92% to 11055.64. The S&P also rose, gaining 1.81% to 3,392.02.
Benzinga · 09/09 14:24
ROCE Insights For Intra-Cellular Therapies
During Q2, Intra-Cellular Therapies's (NASDAQ: ITCI) reported sales totaled $1.91 million. Despite a 32.16% in earnings, the company posted a loss of $64.87 million. Intra-Cellular Therapies collected $1.08 million in revenue during Q1, but reported earnings showed a $49.09 million loss.What Is ROCE
Benzinga · 09/09 14:08
Webull provides a variety of real-time ITCI stock news. You can receive the latest news about INTRA CELLULAR through multiple platforms. This information may help you make smarter investment decisions.